Objectives: We investigated the factors associated with discrepancies between patients' and caregivers' ratings about patients' general quality of life (QoL) and about the domains of Quality of Life in Alzheimer's disease (QoL-AD) Scale at baseline and 12 months.
A lzheimer disease (AD) presents an insidious onset and progressive deterioration. Memory impairment is the main symptom in AD, especially for recent events. 1 The recognition of symptoms by caregivers is associated with early diagnosis, treatment, and safety of patients affected by dementia. 2 Patients who lack awareness, that is, the capacity to recognize changes caused by the deficits related to the disease process, 3 generally refuse required interventions or place themselves at risk while performing activities of daily living (ADL). 2 These situations may impact quality of life (QoL) and well-being of the patient-caregiver dyad.
QoL includes 4 domains: cognitive functioning, ADL, social interaction, and well-being. 4 It is also a subjective phenomenon; hence the validity of patients' and caregivers' ratings is discussed. The evaluation of QoL should be answered from the perspective of the subject. 4, 5 However, in assessments of AD patients' clinical status, the caregivers' ratings are often used, in particular to measure functionality and neuropsychiatric symptoms. Therefore, 1 controversial aspect is that patients' QoL is frequently measured by caregivers' ratings. 4 However, studies suggest that patients with mild and moderate AD can reliably evaluate their own QoL. 4, 5 Nevertheless, there are discrepancies between patients and caregivers about AD patients' QoL, and factors have been associated with divergent ratings. 6, 7 In longitudinal studies, Missotten et al, 8 showed that the functional and cognitive impairments are related to a negative evaluation of QoL by the patient. In contrast, another study indicated that depression and anxiety 9 -but not cognitive decline-may be associated with patients' negative assessment of their own QoL. When the relationship between awareness and QoL was evaluated, CondeSala et al 6 and Hurt et al 10 observed that patients with impaired awareness overestimate their own QoL. In contrast, the factors that negatively impact caregivers' ratings seem to be the impairment in functionality and presence of neuropsychiatric symptoms. 5, 6, 11 A few studies indicate that the caregiver's ratings about the patients' QoL are negatively influenced by caregiver burden 6, 12 and impaired patients' awareness. 6, 13 Therefore, it is observed that the influence of clinical factors on longitudinal evaluation of patients and caregivers requires further clarification.
It is also essential to understand, longitudinally, the increase of discrepancies between patients' and caregivers' ratings about patients' general QoL and about the domains of patients' QoL to observe the maintenance or not of variables (clinical aspects and/or sociodemographic data). Nevertheless, longitudinal studies about the increase of discrepancies between patients' and caregivers' ratings about patients' QoL are rare. Two studies evaluated and found that there were discrepancies in total score and in domains of Quality of Life in Alzheimer's Disease (QoL-AD) Scale. 6, 7 In our previous cross-sectional study, 14 we found discrepancies between patients' and caregivers' ratings about patients' QoL in total score and in the domains of QoL-AD Scale-ability to do chores, memory, and energy. This study aimed to investigate the factors associated with the discrepancies between patients' and caregivers' ratings about patients' QoL in total and the domains of the QoL-AD Scale at baseline and 12 months.
METHODS

Study Design and Participants
The study had a longitudinal design. The data came from a consecutive sample of 114 outpatients seen at the Center for Alzheimer's Disease of the Federal University of Rio de Janeiro (UFRJ). They were all diagnosed as possible or probable AD according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders. 1 Only individuals with mild AD according to the Clinical Dementia Rating (CDR) (CDR = 1 15, 16 ) and Mini-mental State Examination 17,18 scores of 13 to 26 were included in the study. Patients were excluded if they presented aphasia, head trauma, alcohol abuse, or epilepsy, and if they had uncontrolled medical problems, such as hypertension and diabetes. All the caregivers were relatives, who routinely cared for patients' ADL, continuously supervising the patients.
Measures
The sociodemographic characteristics of the patient and caregiver (age, sex, marital status, schooling, and family relationship) were recorded.
Patient Measurements
QoL. The QoL-AD Scale is a 13-item measure of QoL that is completed by both the patients and the caregivers. This questionnaire was developed specifically for the assessment of QoL in patients with AD. The QoL-AD includes 13 domains: physical health, energy, mood, living situation, memory, family, marriage, friends, self, ability to do chores, ability to do things for fun, money, and life as a whole. The 13 domains are rated as poor (1), fair (2), good (3), or excellent (4), and the total score ranges from 13 to 52. 19, 20 The Cronbach α for both patients' and caregivers' ratings were in the high range in the original version (0.88 and 0.87 19 ) and the Brazilian version (0.80 and 0.83, respectively). 20 Cognitive status. The MMSE includes tests of orientation, registration, short-term memory, language use, comprehension, and basic motor skills. The total score ranges from 0 to 30. 17, 18 Dementia severity. The CDR measures the severity of dementia. The stages range from 0 (no dementia) to 3 (severe dementia) according to the degree of cognitive, behavioral, and ADL impairment. 15, 16 Awareness. The Assessment Scale of Psychosocial Impact of the Diagnosis of Dementia (ASPIDD) is a 30-question scale based on patients' and caregivers' ratings. This scale was designed to evaluate awareness in patients through the scoring of discrepant responses between patients and their caregivers across domains that include awareness of cognitive functioning and health condition, ADL, emotional state, and social functioning and relationships. The ratings of awareness are preserved (0 to 4) to absent ( ≥ 18). 3 Depressive symptoms. The Cornell Scale for Depression in Dementia (CSDD) assesses mood symptoms, physical symptoms, circadian functions, and behavioral symptoms related to depression. Scores > 7 indicate the presence of depression. 21, 22 Functionality. The Pfeffer Functional Activities Questionnaire (PFAQ) is a caregiver-reported inventory that evaluates the ADL. The ratings for each item range from normal (0) to dependent (3), with a total of 30 points. 23, 24 Neuropsychiatric symptoms. The Neuropsychiatric Inventory (NPI) evaluates 12 domains: delusions, hallucinations, dysphoria, anxiety, agitation/aggression, euphoria, disinhibition, irritability/lability, apathy, aberrant motor activity, night-time behavior disturbances, and appetite and eating abnormalities. Each item is rated in relation to their frequency [1 (absent) to 4 (frequently)] and intensity 1 (mild) to 3 (severe)]. The total score can range from 0 to 144 points. 25, 26 The Cronbach α for overall reliability was 0.88 25 in the original version and 0.70 in the Brazilian version. 26 
Caregiver Measurements
Burden. The Zarit Burden Interview (ZBI) consists of 22 items. The caregivers assess the impact of the illness on their own lives by indicating how often they experience a particular feeling: never (0) to nearly always (4). The total score ranges from 0 to 88. 27, 28 
Procedure
The interviews and questionnaires were administered to patients and caregivers separately and independently at baseline and at 12 months (2013 to 2015). The patients had their QoL, cognition and awareness assessed. The caregivers provided information about the patients (including sociodemographic, QoL, ADL, neuropsychiatric symptoms, depressive symptoms, and dementia severity) and had caregiver burden assessed. The caregivers were blinded to the statements of the patients. The assessment instruments were administered by a clinical neuropsychology research team from the Dementia Unit.
The psychiatrists from the Dementia Unit identified eligible people according to the inclusion criteria. All of the caregivers had previously been informed of the diagnosis by the psychiatrists. Informed consent was obtained for patients and caregivers. The study was approved by the Ethics Committee of the Institute of Psychiatry at the UFRJ.
Data Analysis
All variables were inspected for normality before analysis. The Mann-Whitney U test for continuous variables and the Pearson χ 2 test for categorical variables were performed for an initial comparison of sociodemographic and clinical characteristics of lost cases of caregivers and patients' between the baseline and 12 months.
The Wilcoxon test was used to assess the discrepancies between patients' and caregivers' ratings of patients' QoL and to identify the discrepancies between ratings in total and various domains of the QoL-AD Scale (physical health, energy, mood, living situation, memory, family, marriage, friends, self, ability to do chores, ability to do things for fun, money, and life as a whole) at baseline and 12 months. We used the Cohen d to measure effect size in relation to discrepancies between patients' and caregivers' QoL-AD scores. The values indicated weak (< 0.5), moderate (0.5-0.8), or high ( > 0.8) effects.
Multivariate linear regression analyses were completed to identify the variables that were associated with the discrepancies between patients' and caregivers' ratings in total and various domains of the QoL-AD Scale at baseline and 12 months. We used the total scores of the discrepancies at baseline and 12 months such as dependent variables. Moreover, we used the domains of the QoL-AD Scale that presented discrepancies with high effect size at 12 months such as dependent variables. The independent variables were the scores of MMSE, CDR, CSDD, PFAQ, ASPIDD, NPI, ZBI, and sociodemographic data. Linear regressions were conducted using the Enter method. All variables were introduced in a single step, adjusting the model with significant variables. In the linear regression analyses, the coefficients of contribution for each variable were calculated by the formula β coefficient×the coefficient of correlation with the dependent variable.
The statistical analysis was performed using the Statistical Package for Social Sciences (IBM Corporation, Armonk, NY) for Windows v. 22.0, with a significance level that was ≤ 0.05 and confidence intervals at 95%.
RESULTS
Clinical and Sociodemographic Data of the Lost Cases
A total of 39 of the 114 baseline cases were lost during the follow-up, because of refusal of the caregiver to be interviewed [21 (53.9%)], medical complications [10 (25.7%)], mobility difficulties [4 (10.3%)], patients' death [3 (7.6%)], and patient's refusal to participate in the interview [1 (2.5%)]. The characteristics related to loss of patients was less schooling. For caregivers, the related factors were high schooling and family relationship. The differences between baseline assessment of follow-up cases and lost cases are shown in Table 1 .
Baseline and Follow-up Scores of Clinical Variables
Scores and significant differences of clinical variables are provided in Table 2 . There were differences at baseline and 12 months in MMSE (P < 0.001), PFAQ (P < 0.001), ASPIDD (P = 0.002), NPI (P = 0.028), and CDR (P < 0.001). We did not find differences in patients' QoL-AD, CSDD, caregivers' QoL-AD of patients, and ZBI at baseline and 12 months.
Discrepancies of Patients' and Caregivers' Ratings of Patients' QoL-AD
Scores and significant discrepancies of patients' and caregivers' ratings of patients' general QoL-AD and of each domain of QoL-AD at baseline and 12 months are provided in Table 3 .
At Baseline
The highest discrepancies between patients' and caregivers' ratings of patients' QoL-AD domains were ability to do chores (d = 0.92), and memory (d = 0.80).
At 12 Months
The highest discrepancies between patients' and caregivers' ratings of patients' QoL-AD domains were memory (d = 1.07), and ability to do chores (d = 0.90).
Multivariate Linear Regression Analyses
At Baseline
Linear regression indicated that the factors associated with discrepancies of patients' and caregivers' ratings of patients' QoL-AD were impaired awareness (P = 0.003) and caregiver burden (P = 0.025). The highest contribution effect was impaired awareness (12.9%).
At 12 Months
Impaired awareness (P < 0.001) was related to discrepancies of patients' and caregivers' ratings of patients' QoL-AD. The contribution effect was impaired awareness (24%). The linear regression analyses are shown in Table 4 .
We did not find a relation between NPI and discrepancies of patients' and caregivers' ratings in both moments, although there was a greater impact at 12 months.
When the effect of patients' total QoL-AD score was analyzed as an independent variable, it explained 15.1% of the discrepancy between patients and caregivers at baseline (r 2 = 0.151, β = 0.38, t = 3.60, P = 0.001) and 30.4% of the discrepancy at 12 months (r 2 = 0.304, β = 0.55, t = 5.64, P < 0.001). Regression analysis was also performed with domains of QoL-AD Scale (memory and ability to do chores) that presented a greater discrepancy between patients' and caregivers' ratings at 12 months. The linear regression analyses are shown in Table 5 .
Memory Domain
Linear regression indicated that the factor associated with discrepancies of patients' and caregivers' ratings of patients' QoL-AD in the domain memory was impaired awareness (P = 0.002).
Ability to Do Chores Domain
Impaired awareness (P = 0.003) and functional deficit (P = 0.012) were related to discrepancies of patients' and caregivers' ratings of patients' QoL-AD in the domain ability to do chores.
DISCUSSION
In this study, there were discrepancies between patients' and the caregivers' ratings of patients' QoL at baseline and also at follow-up, 1 year after the first evaluation. This result is corroborated by other studies that demonstrate the presence of discrepancies in patients' and caregivers' ratings. 6, 7 At baseline, the factors associated with the discrepancy between patients and caregivers were impaired awareness and burden. At 12 months, the discrepancy between patients and caregivers was related to impaired awareness.
Effect of Caregiver Burden on Patients' QoL Assessment
For caregivers, burden is determined by multiple factors: aspects that are related to patients such as level of functional impairment, neuropsychiatric symptoms, and clinical comorbidities; physical, emotional, and social characteristics of the caregiver; caregiver coping capacity, and ability to manage daily the patient's care, social, and health resources. 29 The cross-sectional finding about the influence of burden in discrepancy between patients and caregivers is consistent with recent findings, that demonstrate an association between the caregivers' psychosocial well-being (particularly level of burden and depression) and these discrepancies in ratings of patients' QoL. 6, 30 In a study of factors that influence caregiver evaluations about patient aspects, caregiver burden was the most important factor to explain the variability in assessments, especially in relation to early-stage patients because of greater initial impact of the diagnosis of disease. 29 Caregiver burden can lead to negative assessments of patients' status, particularly in neuropsychiatric symptoms and QoL. 6, 30 Caregivers with moderate levels of burden experience difficulties in managing patients' care and in their daily situations, which negatively affects their ratings about the patients' QoL. 4, 31 Therefore, burden is a multidimensional response to impact caused by the disease. Understanding the elements of patients' disease and the care experience associated with caregiver burden can be useful in predicting a positive or negative evaluation of caregivers about patients' QoL, assisting in daily management with patients.
Effect of Awareness on Patients' QoL Assessment
Another factor that influenced the level of discrepancy was impaired awareness at both baseline and 12 months. 6, 32 The impairment of awareness has been related to more positive patients' ratings about their own QoL and to more negative assessment by caregivers. 7, 14 This lack of awareness suggests that patients' ratings may correspond to a mental image before their disease. 6 Moreover, patients may be only partially aware of some deficits and changes in some domains, but not in others. 10 The individual variability in awareness and its relation to different dimensions may be observed in patients with mild to moderate AD, in studies focusing mainly on the recognition of cognitive deficits. 2 Different domains of awareness have been studied, such as the ability to monitor their own performance, evaluate the functioning of a particular domain and reflect on the nature, and impact of diagnosis. 3, 33 Clare et al 2 suggest that 2 domains of awareness-memory and functionality-show weak correlation with the patients' ratings about their own QoL. Another study indicated significant relationship between patients' ratings of their own QoL and the level of awareness in 3 areas of social-emotional functioning (emotional recognition and empathy, social relations, and prosocial behavior). 33 These aspects illustrate the complexity and heterogeneity of the phenomenon. Future studies may investigate the relationship between patterns of change in QoL and the perception of specific domains of awareness.
Evaluation of QoL in Follow-up
At 12 months, despite the disease progression, the patients' ratings about their own QoL did not change, whereas the caregivers' ratings were slightly worse, even if not statistically significant. Studies indicate that patients scores do not change substantially at follow-up, 8 whereas caregivers' scores significantly decrease. 11 Therefore, the stability of patients' ratings about their own QoL over time is in agreement with several studies that did not find a relation between patients' ratings and cognitive decline. 5, 13 Patients may develop mechanisms to cope with new difficulties that they are facing and may not perceive any decline in their QoL. 7 Another explanation might be that the study of Andrieu et al, 7 did not evaluate the level of impaired awareness. Therefore, it may be assumed that, although the discrepancy is not related to cognitive deficit, the participants demonstrate higher lack of awareness and presence of neuropsychiatric symptoms, which may have contributed to the stability of patients' assessment. This context leads some authors to question the reliability of patients' ratings about their own QoL when they present greater impairment of awareness. The impairment of ability to judge and evaluate, may interfere in patients' perception of their difficulties and lead to underestimation of their importance. 32 Other authors argue that the 2 perspectives (patients' and caregivers') may be considered as equally valid and may highlight different aspects related to QoL. 4, 5 Evaluation of QoL Domains in Follow-up In the evaluation of QoL, we can also analyze multidimensional perception of patients and caregivers, because Multiple linear regression. F = ANOVA; r 2 = coefficient of determination; β = standardized beta coefficient; r = Pearson correlation (0 order); CC = coefficient of contribution (%), [(β.r)×100)].
ASPIDD indicates Assessment Scale of Psychosocial Impact of the Diagnosis of Dementia; FAQ, Functional Activities Questionnaire; NPI, Neuropsychiatric inventory; QoL-AD, Quality of Life-Alzheimer's Disease Scale; TOL, tolerance; VIF, variance inflation factor; ZBI, Zarit Burden Interview.
P < 0.05 are shown in bold.
the QoL-AD Scale measures aspects with regard to cognitive functioning, ADL, social interaction, and well-being in its 13 domains. 4 Multidimensional perception is useful to explain the importance of various domains of QoL, which can approach aspects of clinical practice. 4 At both moments, patients' and caregivers' evaluation in each domain was compared to verify if there was discrepancy. At baseline, we found discrepancies in the domains energy, mood, memory, friends, ability to do chores, and ability to do things for fun. At follow-up, domains with significant difference were energy, mood, memory, family, friends, ability to do chores, ability to do things for fun, and life as a whole. As expected, more domains showed discrepancy at follow-up. This finding may be related to differences between what is relevant for the assessment of patients and caregivers with regard to QoL. Therefore, interpretation may be ambiguous when patients and caregivers are asked to answer the same questions about QoL. 34 Furthermore, we analyzed which variables were related to the domains memory and ability to do chores that presented discrepancies with high effect size at 12 months. In the domain memory, impaired awareness was associated with discrepancies of patients' and caregivers' ratings of patients' QoL-AD, whereas in the domain ability to do chores, impaired awareness and functional deficit were related to discrepancies. It should be emphasized that most patients presented impaired awareness at baseline and this impairment was increased at follow-up; may be patients with memory deficits and decline in other cognitive abilities care less about these abilities. 14 For caregivers, they may perceive the loss of patients' abilities, especially functional deficits, 4, 6 and understand them as a source of suffering for themselves and patients. 34 Therefore, patients' and caregivers' perception are related to individual aspects and both should be both considered in the evaluation of QoL. Besides, some studies 5, 6, 11 highlighted the involvement of a higher frequency of neuropsychiatric symptoms and discrepancies between AD patients' and caregivers' ratings about patients' QoL; we did not find this relation. Although there was a variation in the number of neuropsychiatric symptoms at baseline and follow-up, this was not enough to be correlated with discrepancies' ratings, longitudinally. In addition, our sample was comprised by patients with mild disease at baseline and at follow-up; the majority of the sample was still in the mild stage. Future randomized studies should evaluate the association between the NPI subscales and discrepancies between AD patients' and caregivers' ratings about patients' QoL.
Some limitations of this study must be acknowledged. One limitation is the loss of patients to follow-up since patients who may have had significant variations in QoL may not have been reevaluated. Second, the findings are specific to patients with mild AD and may not be generalizable to other stages of AD. Furthermore, the cognitive status was evaluated only with MMSE. Moreover, the NPI subscales on each of the QoL-AD items were not used, because we were interested in identifying the discrepancies in the QoL-AD items. Finally, clinical aspects of caregivers such as the level of depression and anxiety were not evaluated.
CONCLUSIONS
We identified that discrepancies between patients and caregivers were related to awareness and caregiver burden at baseline and awareness at 12 months. Therefore, the concept of QoL in AD and the discrepancies between patients and caregivers raise questions with regard to the subjective nature of construct and the validity of patients' evaluation about their own QoL.
The relevance of assessing the discrepancy is the possibility to assist the validity of patients' ratings about their own QoL and understanding dimensional aspects of QoL. Furthermore, monitoring of QoL changes in patients with AD may suggest new areas of intervention to maintain or improve QoL of patients and caregivers. Moreover, future studies should identify strategies to improve accuracy and reliability of QoL and other subjective status of patients with AD in order to preserve decision-making and autonomy.
